Effective Targeting of Hepatitis B Virus DNA Using SM-10 Based CRISPR Nanoparticles
CRISPR nanoparticle delivery of Cas9 mRNA and guide RNAs via SM-102-based lipid nanoparticles effectively reduced HBV markers by 53–90% in…
CRISPR nanoparticle delivery of Cas9 mRNA and guide RNAs via SM-102-based lipid nanoparticles effectively reduced HBV markers by 53–90% in…
CRISPR/Cas technology’s endonuclease activity has spurred genome editing, bioanalytical sensors, and disease diagnostics, notably for SARS-CoV-2 variants. Multiplexing capabilities enable…
Advancements in dyslipidemia therapies have evolved from daily small molecules to monoclonal antibodies administered biweekly, and now to RNA-based treatments…
Cellulosic biorefinery, utilizing industrially important proteins like cellulases, holds promise for a zero-waste, sustainable future. However, high production costs and…